World's Best Scientists 2026 revealed!
David W. Dodick

David W. Dodick

David W. Dodick publications per year

The chart shows the history of publications by David W. Dodick between 1969 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. David W. Dodick published across 58 years, from 1969 to 2026, averaging 14.3 papers a year. Output peaked at 62 publications in 2020. 26 of the 830 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1969 to 2026. Vertical axis: number of publications, 0 to 62. Peak 62 publications in 2020. 1969: 1 publication 1970: 0 publications 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 1 publication 1993: 0 publications 1994: 1 publication 1995: 1 publication 1996: 0 publications 1997: 2 publications 1998: 7 publications 1999: 5 publications 2000: 7 publications 2001: 8 publications 2002: 18 publications 2003: 19 publications 2004: 26 publications 2005: 23 publications 2006: 23 publications 2007: 35 publications 2008: 24 publications 2009: 30 publications 2010: 57 publications 2011: 29 publications 2012: 25 publications 2013: 19 publications 2014: 23 publications 2015: 28 publications 2016: 34 publications 2017: 28 publications 2018: 41 publications 2019: 50 publications 2020: 62 publications 2021: 54 publications 2022: 42 publications 2023: 43 publications 2024: 38 publications 2025: 25 publications 2026: 1 publication
1969 2026

830 publications in total across all disciplines

View publications per year as a table
David W. Dodick: publications per year, 1969 to 2026
Year Publications
1969 1
1970 0
1971 0
1972 0
1973 0
1974 0
1975 0
1976 0
1977 0
1978 0
1979 0
1980 0
1981 0
1982 0
1983 0
1984 0
1985 0
1986 0
1987 0
1988 0
1989 0
1990 0
1991 0
1992 1
1993 0
1994 1
1995 1
1996 0
1997 2
1998 7
1999 5
2000 7
2001 8
2002 18
2003 19
2004 26
2005 23
2006 23
2007 35
2008 24
2009 30
2010 57
2011 29
2012 25
2013 19
2014 23
2015 28
2016 34
2017 28
2018 41
2019 50
2020 62
2021 54
2022 42
2023 43
2024 38
2025 25
2026 1
Total 830
Download as CSV

David W. Dodick publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where David W. Dodick sits on this spectrum.

No. of scientists
100 200 300 400 500
Bar chart with 86 bars. Horizontal axis: publications, 38–47 to 887+. Vertical axis: number of scientists, 0 to 539. Most scientists, 539, have 98–107 publications. The last bar groups every scientist with 887 publications or more. 38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientist 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38–47 publications 887+

The last bar groups every scientist with 887 publications or more.

View publications distribution as a table
Number of Neuroscience scientists by publication count, Research.com 2026 ranking edition. Based on 9,597 ranked scientists.
Publications Scientists
38–47 18
48–57 79
58–67 193
68–77 323
78–87 406
88–97 452
98–107 539
108–117 505
118–127 522
128–137 469
138–147 456
148–157 459
158–167 397
168–177 383
178–187 350
188–197 302
198–207 306
208–217 262
218–227 242
228–237 220
238–247 203
248–257 174
258–267 176
268–277 175
278–287 125
288–297 116
298–307 127
308–317 128
318–327 99
328–337 89
338–347 78
348–357 96
358–367 66
368–377 59
378–387 65
388–397 54
398–407 48
408–417 49
418–427 34
428–437 31
438–447 30
448–457 31
458–467 36
468–477 40
478–487 35
488–497 30
498–507 23
508–517 26
518–527 20
528–537 23
538–547 20
548–557 20
558–567 17
568–577 14
578–587 20
588–597 20
598–607 19
608–617 18
618–627 17
628–637 11
638–647 11
648–657 11
658–667 8
668–677 7
678–687 11
688–697 10
698–707 4
708–717 6
718–727 5
728–737 5
738–747 9
748–757 9
758–767 3
768–777 7
778–787 7
788–797 6
798–807 2
808–817 2
818–827 7
828–837 0
838–847 9
848–857 3
858–867 1
868–877 3
878–886 6
887+ 100
Download as CSV

David W. Dodick D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where David W. Dodick sits on this spectrum.

No. of scientists
100 200 300 400 500
Bar chart with 68 bars. Horizontal axis: D-Index, 30–31 to 163+. Vertical axis: number of scientists, 0 to 512. Most scientists, 512, have 46–47 D-Index. The last bar groups every scientist with 163 D-Index or more. 30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30–31 D-Index 163+

The last bar groups every scientist with 163 D-Index or more.

View D-Index distribution as a table
Number of Neuroscience scientists by D-index, Research.com 2026 ranking edition. Based on 9,597 ranked scientists.
D-Index Scientists
30–31 42
32–33 172
34–35 296
36–37 435
38–39 459
40–41 456
42–43 467
44–45 478
46–47 512
48–49 435
50–51 425
52–53 418
54–55 392
56–57 357
58–59 334
60–61 328
62–63 260
64–65 278
66–67 239
68–69 250
70–71 210
72–73 200
74–75 189
76–77 170
78–79 146
80–81 113
82–83 126
84–85 100
86–87 84
88–89 99
90–91 84
92–93 85
94–95 72
96–97 76
98–99 45
100–101 49
102–103 43
104–105 32
106–107 45
108–109 50
110–111 32
112–113 39
114–115 32
116–117 29
118–119 27
120–121 19
122–123 23
124–125 27
126–127 16
128–129 24
130–131 13
132–133 21
134–135 17
136–137 14
138–139 15
140–141 10
142–143 10
144–145 13
146–147 9
148–149 8
150–151 6
152–153 6
154–155 7
156–157 7
158–159 10
160–161 4
162 8
163+ 100
Download as CSV

Overview

David W. Dodick is affiliated with the Mayo Clinic in the United States and has an extensive publication record primarily in the field of Medicine. Their research spans several subfields, including Psychiatry and Mental Health, Pathology and Forensic Medicine, Neurology, Physiology, and Epidemiology.

Their main topics of study involve migraine and headache studies, trigeminal neuralgia and treatments, sympathectomy and hyperhidrosis treatments, psychosomatic disorders and their treatments, traumatic brain injury research, olfactory and sensory function studies, and neurological disorders and treatments.

Frequent coauthors in Dodick's research include:

  • Richard B. Lipton
  • Todd J. Schwedt
  • Peter J. Goadsby
  • Frank Porreca
  • Edita Navratilova

They have published research in various prominent academic venues. The most frequent publication venues for their work are:

  • Neurology
  • Headache The Journal of Head and Face Pain
  • Cephalalgia
  • The Journal of Headache and Pain
  • Alzheimer's & Dementia

David W. Dodick's recent papers include:

  • Migraine, 2022, Nature Reviews Disease Primers
  • National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome, 2021, Neurology
  • Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study, 2020, The Journal of Headache and Pain
  • Migraine: integrated approaches to clinical management and emerging treatments, 2021, The Lancet
  • Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial, 2020, The Lancet Neurology

In addition to journal publications, Dodick has contributed to book literature, including a publication with Oxford University Press titled Oxford Textbook of Headache Syndromes (2020).

Best Publications

  • A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

    Brian G. Weinshenker;Peter C. O'Brien;Tanya M. Petterson;John H. Noseworthy

  • New Appendix Criteria Open for a Broader Concept of Chronic Migraine

    J. Olesen;M -G Bousser;H -C Diener;D. Dodick

  • OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    David W. Dodick;Catherine C. Turkel;Ronald E. Degryse;Sheena K. Aurora

  • Narrative review: reversible cerebral vasoconstriction syndromes.

    Leonard H. Calabrese;David W. Dodick;Todd J. Schwedt;Aneesh B. Singhal

  • Fremanezumab for the Preventive Treatment of Chronic Migraine

    Stephen D. Silberstein;David W. Dodick;Marcelo E. Bigal;Paul P. Yeung

  • Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

    Tony W Ho;Michel D Ferrari;David W Dodick;Vince Galet

  • A self-administered screener for migraine in primary care: The ID Migraine™ validation study

    Richard B. Lipton;D. Dodick;R. Sadovsky;K. Kolodner

  • Migraine

    Unknown

  • Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

    Stephen D. Silberstein;Richard B. Lipton;David W. Dodick;Frederick G. Freitag

  • ARISE: A Phase 3 randomized trial of erenumab for episodic migraine:

    David W Dodick;Messoud Ashina;Jan Lewis Brandes;David Kudrow

  • Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

    Richard B Lipton;David W Dodick;Stephen D Silberstein;Joel R Saper

  • A Phase‐by‐Phase Review of Migraine Pathophysiology

    David W. Dodick

  • Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

    David W Dodick;Peter J Goadsby;Peter J Goadsby;Stephen D Silberstein;Richard B Lipton

  • Adherence to oral migraine-preventive medications among patients with chronic migraine:

    Zsolt Hepp;David W Dodick;Sepideh F Varon;Patrick Gillard

  • Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study

    David W. Dodick;Stephen D. Silberstein;Kenneth L. Reed;Timothy R. Deer

  • Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

    Hong Sun;David William Dodick;Stephen Silberstein;Peter J. Goadsby

  • Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.

    Cristina Tassorelli;Hans-Christoph Diener;David W Dodick;Stephen D Silberstein

  • Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

    Marcelo E Bigal;David W Dodick;Alan M Rapoport;Stephen D Silberstein

  • Ubrogepant for the Treatment of Migraine.

    David W. Dodick;Richard B. Lipton;Jessica Ailani;Kaifeng Lu

  • Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT1B/1D Agonists) in the Acute Treatment of Migraine

    David Dodick;Richard B. Lipton;Vincent Martin;Vasilios Papademetriou

  • A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine:

    Tiffini Voss;Richard B Lipton;David W Dodick;Nicole Dupre

  • Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.

    Richard B. Lipton;David W. Dodick;Jessica Ailani;Kaifeng Lu

  • OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.

    Stephen D. Silberstein;Andrew M. Blumenfeld;Roger K. Cady;Ira M. Turner

Frequent Co-Authors

Richard B. Lipton
Richard B. Lipton Albert Einstein College of Medicine
Julio Pascual
Julio Pascual University of Cantabria
Stewart J. Tepper
Stewart J. Tepper Dartmouth College
Jes Olesen
Jes Olesen University of Copenhagen
Michel D. Ferrari
Michel D. Ferrari Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing David W. Dodick

Trending Scientists

Recently Published Articles